Patents
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
07/2008
07/10/2008US20080167301 Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as Pde4 Inhibitors
07/09/2008EP1940786A1 Biphenyl derivatives and their use in treating hepatitis c
07/09/2008CN100400518C Phthalazinone derivatives
07/08/2008US7396831 Vanilloid receptor ligands and their use in treatments
07/03/2008WO2008080056A2 Pyridazinones and furan-containing compounds
07/03/2008WO2008078674A1 Glucokinase-activating substance
07/03/2008WO2008077507A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase
07/03/2008WO2008041088A3 N-hydroxy benzamides with antitumor activity
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/03/2008US20080160345 Organometallic complex, and light-emitting element, light-emitting device and electronic device including the organometallic compex
07/03/2008CA2673299A1 Pyridazinones compounds for the treatment of proliferative diseases
07/03/2008CA2672088A1 Glucokinase activator
07/02/2008EP1939181A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase
07/02/2008EP1937651A1 Nnrt inhibitors
07/02/2008EP1496838A4 Substituted amides
07/02/2008CN100398103C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
06/2008
06/26/2008US20080153836 1H-Quinazoline-2,4-Diones
06/26/2008US20080153835 Therapeutic agents useful for treating pain
06/25/2008CN101205202A Substituted benzene urea compounds as well as preparation and uses thereof
06/24/2008US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
06/24/2008US7390907 Vanilloid receptor ligands and their use in treatments
06/19/2008WO2008072784A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
06/19/2008WO2008071646A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
06/19/2008US20080146576 N-(1-Phthalazin-1-ylpiperidin-4-yl)amides as EP2 receptor modulators
06/19/2008US20080146575 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one as crystalline; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic with BRCA2 deficient phenotype; septic shock, ischemic injury, multiple sclerosis
06/19/2008US20080146547 e.g. 4-Chloro-1-hydroxy-phthalazine-6-carboxylic acid [4-chloro-3'-(2-dimethylamino-ethoxy)-biphenyl-3-yl]-amide; multifunctioning protein kinase inhibitors; anticarcinogenic, antiinflammatory, antidiabetic agent, neurodegenerative diseases
06/19/2008US20080146546 Bicyclic and Tricyclic Heteroaromatic Compounds
06/19/2008CA2672601A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
06/19/2008CA2671984A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
06/18/2008EP1932835A1 Method for producing 2,3-dihydropyridazine compound
06/18/2008CN101203493A Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
06/17/2008US7388070 inhibitors of DNA polymerase and DNA repair enzymes for treating viral infections, bacterial infections, fungal infections, protozoan infections, and neoplastic diseases; herpes viruses, herpes simplex virus (HSV), and human cytomegalovirus (CMV); peptidomimetics that mimic helical portions of proteins
06/17/2008US7388021 Novel pyridyl or phenyl ureas and analogues; Purinoreceptors inhibitors; 1-(4-tert-butylphenyl)-3-(2-(3-isopropylphenoxy)pyridin-3-yl)urea; for the treatment of a thromboembolic disorders
06/17/2008US7388006 Non-steroidal progesting
06/12/2008WO2007110237A3 Amide derivatives and their application for the treatment of g protein related diseases
06/12/2008US20080139538 Tertiary Carbinamines Having Substituted Heterocycles Which Are Active As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease
06/11/2008EP1928847A2 Theramutein modulators
06/11/2008CN101195599A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols
06/11/2008CN100393713C Therapeutic agents useful for treating pain
06/10/2008US7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof
06/05/2008WO2008012782A3 Labelled analogues of halobenzamides as radiopharmaceuticals
06/05/2008US20080132706 Compounds as PDE IV and TNF Inhibitors
06/05/2008US20080132699 Process For the Preparation of Diazine Derivatives
06/05/2008US20080132698 Use of N-oxide compounds in coupling reactions
06/05/2008US20080132499 Platelet adp receptor inhibitors
06/04/2008EP1926500A2 Methods of making radiolabeled tracers and precursors thereof
06/03/2008US7381725 Pyridazine derivatives as ligands for GABA receptors
06/03/2008US7381719 To treat obesity and Related Diseases; oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; weight loss while maintaining or minimizing the loss of lean muscle mass; 6-[4-(2-Benzylamino-ethyl)-phenoxy]-nicotinamide
05/2008
05/29/2008WO2008062276A2 Acetylene derivatives as stearoyl coa desaturase inhibitors
05/29/2008WO2008062044A1 2-hydroxy-1,3-diaminopropane derivatives
05/29/2008WO2008062012A1 Pyridazin-4-ylmethyl-sulfonamides used as fungicides and against arthropods
05/29/2008US20080121873 Organic Thin Film Transistor Material, Organic Thin Film Transistor, Field-Effect Transistor, Switching Element, Organic Semiconductor Material and Organic Semiconductor Film
05/29/2008CA2669839A1 2-hydroxy-1,3-diaminopropane derivatives
05/29/2008CA2668578A1 Pyridazin-4-ylmethyl-sulfonamides used as fungicides
05/28/2008CN101189221A AMPA receptor potentiators
05/28/2008CN100390152C Method for synthesizing 3-nitro or 3-amino phthalyl hydrazine
05/27/2008US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
05/27/2008US7378522 Such as 6-(4-Acetamidophenoxy)-5-(N-benzyl-N-methylaminomethyl)-1-(2',6'-difluorobenzyl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid-ethyl ester; rapid effectiveness, bioavailability; low cost, simple synthesis
05/22/2008WO2008061108A2 Phthalazine derivatives
05/22/2008US20080119491 Amidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
05/22/2008US20080119474 5,6-bis(4-methoxyphenyl)-2-ethyl-2H-pyridazin-3-one; interleukin-1 beta antagonist; collagenase inhibitor; analgesic, antiinflammatory, antiarthritic, antiischemic agents; autoimmune disease, rheumatic diseases; osteoporosis
05/22/2008US20080119468 Phthalazine, aza-and diaza-phthalazine compounds and methods of use
05/21/2008EP1922307A2 Heterocyclic inhibitors of mek and methods of use thereof
05/21/2008EP1562595B1 Diaryl ethers as opioid receptor antagonists
05/21/2008EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
05/21/2008EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
05/21/2008CN101184395A Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
05/15/2008WO2008057873A2 Inhibitors of hepatitis c virus
05/15/2008WO2008057871A2 Inhibitors of hepatitis c virus
05/15/2008WO2008057282A1 Calcium receptor modulating agents
05/15/2008WO2008056897A1 Caspase inhibitors based on pyridazinone scaffold
05/15/2008CA2668281A1 Caspase inhibitors based on pyridazinone scaffold
05/14/2008EP1919879A1 9-aminocarbonylsubstituted derivatives of glycylcyclines
05/14/2008EP1919878A1 Pyridazinone derivatives as thyroid hormone receptor agonists
05/14/2008EP1575922B1 Biphenyl derivatives and their use as fungicides
05/14/2008EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
05/13/2008US7371755 Antiviral agents
05/13/2008US7371753 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
05/08/2008WO2008053043A1 Process for preparing difluoromethylpyrazolyl carboxylates
05/08/2008WO2008052441A1 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
05/08/2008WO2008024302A8 Compounds for treating proliferative disorders
05/08/2008US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation
05/08/2008US20080108810 Prepared by reacting 2,3,4-trifluoronitrobenzene with an alkali metal aryloxide, contacting product with an alkali metal salt of a malonate diester to replace 4-fluoro group with malonate; optional further hydrolysis, reduction of the NO2 group, and decarboxylation; use in treatment of HIV
05/08/2008US20080108601 anticancer agents; catalytic hydrogenation
05/08/2008CA2666746A1 Process for preparing difluoromethylpyrazolyl carboxylates
05/07/2008EP1917323A1 Novel materials for organic electroluminescent devices
05/02/2008WO2008049585A1 Pyridazine derivatives
05/02/2008WO2008049584A1 Novel pyridazine derivatives
05/02/2008CA2667398A1 Novel pyridazine derivatives
05/02/2008CA2667235A1 Pyridazine derivatives
05/01/2008US20080103180 CCR9 inhibitors and methods of use thereof
04/2008
04/30/2008EP1916240A1 Pyridazine derivatives
04/30/2008EP1543096B1 Alkyl-succinhydrazide additives for lubricants
04/29/2008US7365072 Inhibitors of p38
04/29/2008US7365071 Heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as β-lactamase inhibitors and antibacterials
04/29/2008US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate
04/29/2008CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
04/24/2008WO2008047082A2 Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one
04/24/2008US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
04/24/2008US20080096883 Trifluoromethyl substituted benzamides as kinase inhibitors
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 85